128 related articles for article (PubMed ID: 8751553)
1. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia.
Dellas A; Schultheiss E; Almendral AC; Torhost J; Gudat F
Gynecol Oncol; 1996 Aug; 62(2):218-25. PubMed ID: 8751553
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study.
Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
Eur J Gynaecol Oncol; 1998; 19(1):46-9. PubMed ID: 9476059
[TBL] [Abstract][Full Text] [Related]
3. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
Saegusa M; Hashimura M; Machida D; Okayasu I
J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of CD44 splice variant expression in premalignant lesions of the cervix and benign cervical epithelium.
Kohlberger PD; Kieback DG; Bancher D; Stickeler E; Heinzl H; Gitsch G; Breitenecker G; Kainz C
Gynecol Oncol; 1997 Aug; 66(2):227-32. PubMed ID: 9264567
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study.
Faleiro-Rodrigues C; Lopes C
Pathobiology; 2004; 71(6):329-36. PubMed ID: 15627844
[TBL] [Abstract][Full Text] [Related]
7. E-Cadherin and CD44 expression in cervical intraepithelial neoplasia: comparison between HIV-positive and HIV-negative women and correlation with HPV status.
Daraï E; Walker-Combrouze F; Bénifla JL; Hénin D; Feldmann G; Madelenat P; Scoazec JY
Gynecol Oncol; 2000 Jan; 76(1):56-62. PubMed ID: 10620442
[TBL] [Abstract][Full Text] [Related]
8. Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.
Noel JC; Fernandez-Aguilar S; Fayt I; Buxant F; Ansion MH; Simon P; Anaf V
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1119-23. PubMed ID: 16232183
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
10. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2000 Dec; 192(4):494-501. PubMed ID: 11113867
[TBL] [Abstract][Full Text] [Related]
11. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
[TBL] [Abstract][Full Text] [Related]
12. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
Kalof AN; Evans MF; Simmons-Arnold L; Beatty BG; Cooper K
Am J Surg Pathol; 2005 May; 29(5):674-9. PubMed ID: 15832093
[TBL] [Abstract][Full Text] [Related]
13. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
[TBL] [Abstract][Full Text] [Related]
14. CD44 splice variant expression in clear cell carcinoma of the ovary.
Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
[TBL] [Abstract][Full Text] [Related]
15. Expression and modulation of CD44 variant isoforms in humans.
Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen SM; Favalli C; Syrjänen K;
Int J Gynecol Pathol; 2006 Oct; 25(4):383-92. PubMed ID: 16990717
[TBL] [Abstract][Full Text] [Related]
17. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer.
Tornesello ML; Duraturo ML; Salatiello I; Buonaguro L; Losito S; Botti G; Stellato G; Greggi S; Piccoli R; Pilotti S; Stefanon B; De Palo G; Franceschi S; Buonaguro FM
J Med Virol; 2004 Sep; 74(1):117-26. PubMed ID: 15258977
[TBL] [Abstract][Full Text] [Related]
19. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]